nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0658	0.102	CbGbCtD
Sumatriptan—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0595	0.0925	CbGbCtD
Sumatriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0577	0.0898	CbGbCtD
Sumatriptan—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0562	0.0874	CbGbCtD
Sumatriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0554	0.0861	CbGbCtD
Sumatriptan—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0549	0.0854	CbGbCtD
Sumatriptan—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0485	0.0754	CbGbCtD
Sumatriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0347	0.0539	CbGbCtD
Sumatriptan—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0323	0.0502	CbGbCtD
Sumatriptan—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0305	0.0475	CbGbCtD
Sumatriptan—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0278	0.0433	CbGbCtD
Sumatriptan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0264	0.0411	CbGbCtD
Sumatriptan—ABCG2—Glyburide—type 2 diabetes mellitus	0.0242	0.0376	CbGbCtD
Sumatriptan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0236	0.0367	CbGbCtD
Sumatriptan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.017	0.0265	CbGbCtD
Sumatriptan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0182	CbGbCtD
Sumatriptan—ABCB1—Glyburide—type 2 diabetes mellitus	0.00872	0.0136	CbGbCtD
Sumatriptan—ABCB1—Losartan—type 2 diabetes mellitus	0.00798	0.0124	CbGbCtD
Sumatriptan—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00197	0.351	CrCbGaD
Sumatriptan—HTR3A—nerve—type 2 diabetes mellitus	0.00183	0.0999	CbGeAlD
Sumatriptan—HTR1B—artery—type 2 diabetes mellitus	0.00155	0.0845	CbGeAlD
Sumatriptan—HTR1D—artery—type 2 diabetes mellitus	0.0015	0.0818	CbGeAlD
Sumatriptan—MAOA—nerve—type 2 diabetes mellitus	0.00113	0.0618	CbGeAlD
Sumatriptan—DRD2—nerve—type 2 diabetes mellitus	0.00112	0.0611	CbGeAlD
Sumatriptan—Melatonin—MTNR1B—type 2 diabetes mellitus	0.00103	0.185	CrCbGaD
Sumatriptan—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000885	0.0484	CbGeAlD
Sumatriptan—Melatonin—CALM1—type 2 diabetes mellitus	0.000633	0.113	CrCbGaD
Sumatriptan—SLCO1B1—kidney—type 2 diabetes mellitus	0.000608	0.0332	CbGeAlD
Sumatriptan—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000548	0.0299	CbGeAlD
Sumatriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000537	0.0294	CbGeAlD
Sumatriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.00052	0.0284	CbGeAlD
Sumatriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000509	0.0278	CbGeAlD
Sumatriptan—SLCO1A2—kidney—type 2 diabetes mellitus	0.000495	0.027	CbGeAlD
Sumatriptan—MAOA—retina—type 2 diabetes mellitus	0.000468	0.0256	CbGeAlD
Sumatriptan—DRD2—retina—type 2 diabetes mellitus	0.000463	0.0253	CbGeAlD
Sumatriptan—MAOA—nephron tubule—type 2 diabetes mellitus	0.000441	0.0241	CbGeAlD
Sumatriptan—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000434	0.0237	CbGeAlD
Sumatriptan—Rizatriptan—CYP1A2—type 2 diabetes mellitus	0.000425	0.076	CrCbGaD
Sumatriptan—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000396	0.0216	CbGeAlD
Sumatriptan—Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.000389	0.0695	CrCbGaD
Sumatriptan—MAOA—kidney—type 2 diabetes mellitus	0.000388	0.0212	CbGeAlD
Sumatriptan—MAOA—pancreas—type 2 diabetes mellitus	0.000385	0.021	CbGeAlD
Sumatriptan—SLCO1B1—liver—type 2 diabetes mellitus	0.000384	0.021	CbGeAlD
Sumatriptan—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000382	0.0209	CbGeAlD
Sumatriptan—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000377	0.0206	CbGeAlD
Sumatriptan—MAOA—adipose tissue—type 2 diabetes mellitus	0.000349	0.0191	CbGeAlD
Sumatriptan—SLCO1A2—liver—type 2 diabetes mellitus	0.000313	0.0171	CbGeAlD
Sumatriptan—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.00031	0.0553	CrCbGaD
Sumatriptan—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000303	0.0165	CbGeAlD
Sumatriptan—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000295	0.0527	CrCbGaD
Sumatriptan—MAOA—liver—type 2 diabetes mellitus	0.000245	0.0134	CbGeAlD
Sumatriptan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000234	0.0128	CbGeAlD
Sumatriptan—ABCG2—liver—type 2 diabetes mellitus	0.000212	0.0116	CbGeAlD
Sumatriptan—ABCB1—retina—type 2 diabetes mellitus	0.0002	0.0109	CbGeAlD
Sumatriptan—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000199	0.0356	CrCbGaD
Sumatriptan—Almotriptan—CYP3A4—type 2 diabetes mellitus	0.000195	0.0349	CrCbGaD
Sumatriptan—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000189	0.0103	CbGeAlD
Sumatriptan—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000169	0.00925	CbGeAlD
Sumatriptan—ABCB1—kidney—type 2 diabetes mellitus	0.000166	0.00905	CbGeAlD
Sumatriptan—ABCB1—pancreas—type 2 diabetes mellitus	0.000165	0.00899	CbGeAlD
Sumatriptan—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000161	0.00882	CbGeAlD
Sumatriptan—Eletriptan—CYP3A4—type 2 diabetes mellitus	0.000152	0.0272	CrCbGaD
Sumatriptan—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000149	0.00816	CbGeAlD
Sumatriptan—ABCB1—liver—type 2 diabetes mellitus	0.000105	0.00572	CbGeAlD
Sumatriptan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000345	CcSEcCtD
Sumatriptan—Agitation—Losartan—type 2 diabetes mellitus	7.89e-05	0.000345	CcSEcCtD
Sumatriptan—Oedema—Metformin—type 2 diabetes mellitus	7.89e-05	0.000345	CcSEcCtD
Sumatriptan—Tinnitus—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000345	CcSEcCtD
Sumatriptan—Hypertension—Irbesartan—type 2 diabetes mellitus	7.87e-05	0.000345	CcSEcCtD
Sumatriptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.86e-05	0.000344	CcSEcCtD
Sumatriptan—Flushing—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000343	CcSEcCtD
Sumatriptan—Angioedema—Losartan—type 2 diabetes mellitus	7.84e-05	0.000343	CcSEcCtD
Sumatriptan—Infection—Metformin—type 2 diabetes mellitus	7.83e-05	0.000343	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.8e-05	0.000341	CcSEcCtD
Sumatriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.78e-05	0.00034	CcSEcCtD
Sumatriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.00034	CcSEcCtD
Sumatriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.00034	CcSEcCtD
Sumatriptan—Chest pain—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.00034	CcSEcCtD
Sumatriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.00034	CcSEcCtD
Sumatriptan—Shock—Metformin—type 2 diabetes mellitus	7.76e-05	0.00034	CcSEcCtD
Sumatriptan—Malaise—Losartan—type 2 diabetes mellitus	7.74e-05	0.000339	CcSEcCtD
Sumatriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000339	CcSEcCtD
Sumatriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.73e-05	0.000339	CcSEcCtD
Sumatriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.73e-05	0.000339	CcSEcCtD
Sumatriptan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.72e-05	0.000338	CcSEcCtD
Sumatriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000338	CcSEcCtD
Sumatriptan—Vertigo—Losartan—type 2 diabetes mellitus	7.71e-05	0.000337	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.000337	CcSEcCtD
Sumatriptan—Somnolence—Valsartan—type 2 diabetes mellitus	7.7e-05	0.000337	CcSEcCtD
Sumatriptan—Syncope—Losartan—type 2 diabetes mellitus	7.7e-05	0.000337	CcSEcCtD
Sumatriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000336	CcSEcCtD
Sumatriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000336	CcSEcCtD
Sumatriptan—Skin disorder—Metformin—type 2 diabetes mellitus	7.66e-05	0.000335	CcSEcCtD
Sumatriptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000334	CcSEcCtD
Sumatriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.62e-05	0.000334	CcSEcCtD
Sumatriptan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000333	CcSEcCtD
Sumatriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.000332	CcSEcCtD
Sumatriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000332	CcSEcCtD
Sumatriptan—Palpitations—Losartan—type 2 diabetes mellitus	7.58e-05	0.000332	CcSEcCtD
Sumatriptan—Nausea—Glimepiride—type 2 diabetes mellitus	7.56e-05	0.000331	CcSEcCtD
Sumatriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000331	CcSEcCtD
Sumatriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.54e-05	0.00033	CcSEcCtD
Sumatriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	7.54e-05	0.00033	CcSEcCtD
Sumatriptan—Asthenia—Glyburide—type 2 diabetes mellitus	7.53e-05	0.00033	CcSEcCtD
Sumatriptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.53e-05	0.00033	CcSEcCtD
Sumatriptan—Cough—Losartan—type 2 diabetes mellitus	7.49e-05	0.000328	CcSEcCtD
Sumatriptan—Urticaria—Gliclazide—type 2 diabetes mellitus	7.49e-05	0.000328	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.48e-05	0.000327	CcSEcCtD
Sumatriptan—Fatigue—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000327	CcSEcCtD
Sumatriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000326	CcSEcCtD
Sumatriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000326	CcSEcCtD
Sumatriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000326	CcSEcCtD
Sumatriptan—Oedema—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000326	CcSEcCtD
Sumatriptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.44e-05	0.000326	CcSEcCtD
Sumatriptan—Pruritus—Glyburide—type 2 diabetes mellitus	7.43e-05	0.000325	CcSEcCtD
Sumatriptan—Constipation—Valsartan—type 2 diabetes mellitus	7.41e-05	0.000324	CcSEcCtD
Sumatriptan—Infection—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000324	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.39e-05	0.000323	CcSEcCtD
Sumatriptan—Fatigue—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000323	CcSEcCtD
Sumatriptan—Hypotension—Metformin—type 2 diabetes mellitus	7.37e-05	0.000323	CcSEcCtD
Sumatriptan—Erythema—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000322	CcSEcCtD
Sumatriptan—Shock—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.00032	CcSEcCtD
Sumatriptan—Pain—Orlistat—type 2 diabetes mellitus	7.32e-05	0.00032	CcSEcCtD
Sumatriptan—Chest pain—Losartan—type 2 diabetes mellitus	7.31e-05	0.00032	CcSEcCtD
Sumatriptan—Myalgia—Losartan—type 2 diabetes mellitus	7.31e-05	0.00032	CcSEcCtD
Sumatriptan—Arthralgia—Losartan—type 2 diabetes mellitus	7.31e-05	0.00032	CcSEcCtD
Sumatriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.3e-05	0.00032	CcSEcCtD
Sumatriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.3e-05	0.000319	CcSEcCtD
Sumatriptan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.000319	CcSEcCtD
Sumatriptan—Anxiety—Losartan—type 2 diabetes mellitus	7.28e-05	0.000319	CcSEcCtD
Sumatriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000318	CcSEcCtD
Sumatriptan—Rash—Bromocriptine—type 2 diabetes mellitus	7.24e-05	0.000317	CcSEcCtD
Sumatriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.23e-05	0.000317	CcSEcCtD
Sumatriptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000316	CcSEcCtD
Sumatriptan—Discomfort—Losartan—type 2 diabetes mellitus	7.22e-05	0.000316	CcSEcCtD
Sumatriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000315	CcSEcCtD
Sumatriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000315	CcSEcCtD
Sumatriptan—Headache—Bromocriptine—type 2 diabetes mellitus	7.19e-05	0.000315	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.18e-05	0.000314	CcSEcCtD
Sumatriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.18e-05	0.000314	CcSEcCtD
Sumatriptan—Dry mouth—Losartan—type 2 diabetes mellitus	7.15e-05	0.000313	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.08e-05	0.00031	CcSEcCtD
Sumatriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	7.08e-05	0.00031	CcSEcCtD
Sumatriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.07e-05	0.00031	CcSEcCtD
Sumatriptan—Confusional state—Losartan—type 2 diabetes mellitus	7.06e-05	0.000309	CcSEcCtD
Sumatriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.05e-05	0.000309	CcSEcCtD
Sumatriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	7.03e-05	0.000308	CcSEcCtD
Sumatriptan—Somnolence—Metformin—type 2 diabetes mellitus	7.01e-05	0.000307	CcSEcCtD
Sumatriptan—Oedema—Losartan—type 2 diabetes mellitus	7e-05	0.000307	CcSEcCtD
Sumatriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7e-05	0.000307	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7e-05	0.000306	CcSEcCtD
Sumatriptan—Infection—Losartan—type 2 diabetes mellitus	6.96e-05	0.000305	CcSEcCtD
Sumatriptan—Hypotension—Irbesartan—type 2 diabetes mellitus	6.95e-05	0.000304	CcSEcCtD
Sumatriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.94e-05	0.000304	CcSEcCtD
Sumatriptan—Tremor—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000302	CcSEcCtD
Sumatriptan—Shock—Losartan—type 2 diabetes mellitus	6.89e-05	0.000302	CcSEcCtD
Sumatriptan—Urticaria—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000301	CcSEcCtD
Sumatriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.87e-05	0.000301	CcSEcCtD
Sumatriptan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.86e-05	0.0003	CcSEcCtD
Sumatriptan—Decreased appetite—Metformin—type 2 diabetes mellitus	6.86e-05	0.0003	CcSEcCtD
Sumatriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.85e-05	0.0003	CcSEcCtD
Sumatriptan—Tachycardia—Losartan—type 2 diabetes mellitus	6.84e-05	0.000299	CcSEcCtD
Sumatriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000299	CcSEcCtD
Sumatriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	6.82e-05	0.000299	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.81e-05	0.000298	CcSEcCtD
Sumatriptan—Fatigue—Metformin—type 2 diabetes mellitus	6.8e-05	0.000298	CcSEcCtD
Sumatriptan—Urticaria—Orlistat—type 2 diabetes mellitus	6.8e-05	0.000298	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000297	CcSEcCtD
Sumatriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.77e-05	0.000296	CcSEcCtD
Sumatriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Sumatriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Sumatriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Sumatriptan—Agitation—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Sumatriptan—Constipation—Metformin—type 2 diabetes mellitus	6.74e-05	0.000295	CcSEcCtD
Sumatriptan—Angioedema—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000294	CcSEcCtD
Sumatriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000293	CcSEcCtD
Sumatriptan—Vomiting—Glyburide—type 2 diabetes mellitus	6.67e-05	0.000292	CcSEcCtD
Sumatriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	6.67e-05	0.000292	CcSEcCtD
Sumatriptan—Malaise—Ramipril—type 2 diabetes mellitus	6.64e-05	0.00029	CcSEcCtD
Sumatriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.00029	CcSEcCtD
Sumatriptan—Rash—Glyburide—type 2 diabetes mellitus	6.62e-05	0.00029	CcSEcCtD
Sumatriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.00029	CcSEcCtD
Sumatriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	6.61e-05	0.000289	CcSEcCtD
Sumatriptan—Vertigo—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000289	CcSEcCtD
Sumatriptan—Syncope—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000289	CcSEcCtD
Sumatriptan—Headache—Glyburide—type 2 diabetes mellitus	6.58e-05	0.000288	CcSEcCtD
Sumatriptan—Hypotension—Losartan—type 2 diabetes mellitus	6.54e-05	0.000286	CcSEcCtD
Sumatriptan—Palpitations—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000285	CcSEcCtD
Sumatriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.5e-05	0.000284	CcSEcCtD
Sumatriptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000283	CcSEcCtD
Sumatriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000283	CcSEcCtD
Sumatriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000282	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.45e-05	0.000282	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000281	CcSEcCtD
Sumatriptan—Cough—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000281	CcSEcCtD
Sumatriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000281	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.38e-05	0.000279	CcSEcCtD
Sumatriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.38e-05	0.000279	CcSEcCtD
Sumatriptan—Convulsion—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000279	CcSEcCtD
Sumatriptan—Constipation—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000279	CcSEcCtD
Sumatriptan—Pain—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000279	CcSEcCtD
Sumatriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.3e-05	0.000276	CcSEcCtD
Sumatriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	6.29e-05	0.000275	CcSEcCtD
Sumatriptan—Urticaria—Metformin—type 2 diabetes mellitus	6.26e-05	0.000274	CcSEcCtD
Sumatriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000274	CcSEcCtD
Sumatriptan—Chest pain—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000274	CcSEcCtD
Sumatriptan—Myalgia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000274	CcSEcCtD
Sumatriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	6.24e-05	0.000273	CcSEcCtD
Sumatriptan—Anxiety—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000273	CcSEcCtD
Sumatriptan—Nausea—Glyburide—type 2 diabetes mellitus	6.24e-05	0.000273	CcSEcCtD
Sumatriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	6.23e-05	0.000273	CcSEcCtD
Sumatriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000273	CcSEcCtD
Sumatriptan—Somnolence—Losartan—type 2 diabetes mellitus	6.23e-05	0.000273	CcSEcCtD
Sumatriptan—Asthenia—Valsartan—type 2 diabetes mellitus	6.21e-05	0.000272	CcSEcCtD
Sumatriptan—Discomfort—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000271	CcSEcCtD
Sumatriptan—Asthenia—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000269	CcSEcCtD
Sumatriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.000268	CcSEcCtD
Sumatriptan—Pruritus—Valsartan—type 2 diabetes mellitus	6.13e-05	0.000268	CcSEcCtD
Sumatriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000268	CcSEcCtD
Sumatriptan—Decreased appetite—Losartan—type 2 diabetes mellitus	6.09e-05	0.000267	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000266	CcSEcCtD
Sumatriptan—Confusional state—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000265	CcSEcCtD
Sumatriptan—Pruritus—Orlistat—type 2 diabetes mellitus	6.05e-05	0.000265	CcSEcCtD
Sumatriptan—Fatigue—Losartan—type 2 diabetes mellitus	6.04e-05	0.000264	CcSEcCtD
Sumatriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000263	CcSEcCtD
Sumatriptan—Oedema—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000263	CcSEcCtD
Sumatriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	5.99e-05	0.000262	CcSEcCtD
Sumatriptan—Constipation—Losartan—type 2 diabetes mellitus	5.99e-05	0.000262	CcSEcCtD
Sumatriptan—Pain—Losartan—type 2 diabetes mellitus	5.99e-05	0.000262	CcSEcCtD
Sumatriptan—Rash—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.00026	CcSEcCtD
Sumatriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.00026	CcSEcCtD
Sumatriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.93e-05	0.000259	CcSEcCtD
Sumatriptan—Urticaria—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000259	CcSEcCtD
Sumatriptan—Shock—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000259	CcSEcCtD
Sumatriptan—Headache—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.000258	CcSEcCtD
Sumatriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000258	CcSEcCtD
Sumatriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000258	CcSEcCtD
Sumatriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000258	CcSEcCtD
Sumatriptan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000257	CcSEcCtD
Sumatriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000257	CcSEcCtD
Sumatriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.85e-05	0.000256	CcSEcCtD
Sumatriptan—Skin disorder—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000255	CcSEcCtD
Sumatriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000254	CcSEcCtD
Sumatriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.77e-05	0.000253	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.73e-05	0.000251	CcSEcCtD
Sumatriptan—Dizziness—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000251	CcSEcCtD
Sumatriptan—Dizziness—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000248	CcSEcCtD
Sumatriptan—Asthenia—Metformin—type 2 diabetes mellitus	5.66e-05	0.000248	CcSEcCtD
Sumatriptan—Hypotension—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000246	CcSEcCtD
Sumatriptan—Nausea—Gliclazide—type 2 diabetes mellitus	5.6e-05	0.000245	CcSEcCtD
Sumatriptan—Pruritus—Metformin—type 2 diabetes mellitus	5.58e-05	0.000244	CcSEcCtD
Sumatriptan—Urticaria—Losartan—type 2 diabetes mellitus	5.56e-05	0.000244	CcSEcCtD
Sumatriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	5.54e-05	0.000242	CcSEcCtD
Sumatriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	5.54e-05	0.000242	CcSEcCtD
Sumatriptan—Vomiting—Valsartan—type 2 diabetes mellitus	5.51e-05	0.000241	CcSEcCtD
Sumatriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.00024	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000239	CcSEcCtD
Sumatriptan—Rash—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000239	CcSEcCtD
Sumatriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000239	CcSEcCtD
Sumatriptan—Vomiting—Orlistat—type 2 diabetes mellitus	5.44e-05	0.000238	CcSEcCtD
Sumatriptan—Headache—Valsartan—type 2 diabetes mellitus	5.43e-05	0.000237	CcSEcCtD
Sumatriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	5.4e-05	0.000236	CcSEcCtD
Sumatriptan—Rash—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000236	CcSEcCtD
Sumatriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000236	CcSEcCtD
Sumatriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	5.39e-05	0.000236	CcSEcCtD
Sumatriptan—Headache—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000235	CcSEcCtD
Sumatriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000234	CcSEcCtD
Sumatriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000234	CcSEcCtD
Sumatriptan—Somnolence—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000234	CcSEcCtD
Sumatriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.00023	CcSEcCtD
Sumatriptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000229	CcSEcCtD
Sumatriptan—Dizziness—Metformin—type 2 diabetes mellitus	5.21e-05	0.000228	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000227	CcSEcCtD
Sumatriptan—Fatigue—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000227	CcSEcCtD
Sumatriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.16e-05	0.000226	CcSEcCtD
Sumatriptan—Nausea—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000225	CcSEcCtD
Sumatriptan—Constipation—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000225	CcSEcCtD
Sumatriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000223	CcSEcCtD
Sumatriptan—Nausea—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000222	CcSEcCtD
Sumatriptan—Asthenia—Losartan—type 2 diabetes mellitus	5.03e-05	0.00022	CcSEcCtD
Sumatriptan—Vomiting—Metformin—type 2 diabetes mellitus	5.01e-05	0.000219	CcSEcCtD
Sumatriptan—Rash—Metformin—type 2 diabetes mellitus	4.97e-05	0.000218	CcSEcCtD
Sumatriptan—Dermatitis—Metformin—type 2 diabetes mellitus	4.97e-05	0.000217	CcSEcCtD
Sumatriptan—Pruritus—Losartan—type 2 diabetes mellitus	4.96e-05	0.000217	CcSEcCtD
Sumatriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000217	CcSEcCtD
Sumatriptan—Headache—Metformin—type 2 diabetes mellitus	4.94e-05	0.000216	CcSEcCtD
Sumatriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000215	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000215	CcSEcCtD
Sumatriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	4.79e-05	0.00021	CcSEcCtD
Sumatriptan—Urticaria—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000209	CcSEcCtD
Sumatriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000208	CcSEcCtD
Sumatriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000208	CcSEcCtD
Sumatriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000207	CcSEcCtD
Sumatriptan—Rash—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000205	CcSEcCtD
Sumatriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000205	CcSEcCtD
Sumatriptan—Nausea—Metformin—type 2 diabetes mellitus	4.68e-05	0.000205	CcSEcCtD
Sumatriptan—Headache—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000204	CcSEcCtD
Sumatriptan—Dizziness—Losartan—type 2 diabetes mellitus	4.63e-05	0.000203	CcSEcCtD
Sumatriptan—Vomiting—Losartan—type 2 diabetes mellitus	4.45e-05	0.000195	CcSEcCtD
Sumatriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000194	CcSEcCtD
Sumatriptan—Nausea—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000193	CcSEcCtD
Sumatriptan—Rash—Losartan—type 2 diabetes mellitus	4.42e-05	0.000193	CcSEcCtD
Sumatriptan—Dermatitis—Losartan—type 2 diabetes mellitus	4.41e-05	0.000193	CcSEcCtD
Sumatriptan—Headache—Losartan—type 2 diabetes mellitus	4.39e-05	0.000192	CcSEcCtD
Sumatriptan—Asthenia—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000189	CcSEcCtD
Sumatriptan—Pruritus—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000186	CcSEcCtD
Sumatriptan—Nausea—Losartan—type 2 diabetes mellitus	4.16e-05	0.000182	CcSEcCtD
Sumatriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.11e-05	0.00018	CcSEcCtD
Sumatriptan—Dizziness—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000174	CcSEcCtD
Sumatriptan—Vomiting—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000167	CcSEcCtD
Sumatriptan—Rash—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000166	CcSEcCtD
Sumatriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000166	CcSEcCtD
Sumatriptan—Headache—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000165	CcSEcCtD
Sumatriptan—Nausea—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000156	CcSEcCtD
Sumatriptan—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.57e-06	7.22e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.55e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—LEP—type 2 diabetes mellitus	7.55e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—type 2 diabetes mellitus	7.55e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	7.54e-06	7.19e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.51e-06	7.16e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.51e-06	7.16e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.51e-06	7.16e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.49e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.46e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	7.46e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.46e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.44e-06	7.1e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	7.44e-06	7.1e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.41e-06	7.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.39e-06	7.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	7.39e-06	7.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	7.39e-06	7.05e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.38e-06	7.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.37e-06	7.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.34e-06	7e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.34e-06	7e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	7.33e-06	6.99e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	7.31e-06	6.97e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.3e-06	6.97e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	7.3e-06	6.96e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.28e-06	6.94e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.28e-06	6.94e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	7.27e-06	6.93e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.24e-06	6.91e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	7.22e-06	6.89e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.21e-06	6.88e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.2e-06	6.86e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.15e-06	6.82e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.15e-06	6.82e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.15e-06	6.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.14e-06	6.81e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	7.13e-06	6.8e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.12e-06	6.79e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.11e-06	6.78e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.09e-06	6.76e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.03e-06	6.71e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.03e-06	6.71e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.02e-06	6.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7e-06	6.68e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.98e-06	6.66e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.97e-06	6.64e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.92e-06	6.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.91e-06	6.59e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	6.91e-06	6.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.9e-06	6.58e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.9e-06	6.58e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	6.9e-06	6.58e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.88e-06	6.56e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	6.79e-06	6.48e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.77e-06	6.46e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	6.77e-06	6.45e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—INS—type 2 diabetes mellitus	6.76e-06	6.45e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.73e-06	6.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.71e-06	6.4e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	6.69e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	6.69e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.59e-06	6.29e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.57e-06	6.27e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SRC—type 2 diabetes mellitus	6.54e-06	6.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.54e-06	6.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.48e-06	6.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—INS—type 2 diabetes mellitus	6.45e-06	6.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.41e-06	6.12e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.41e-06	6.12e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.41e-06	6.12e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	6.4e-06	6.11e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.4e-06	6.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.39e-06	6.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.39e-06	6.09e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.37e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	6.37e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.36e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.34e-06	6.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.33e-06	6.04e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	6.31e-06	6.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.3e-06	6.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.3e-06	6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.27e-06	5.98e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	6.24e-06	5.95e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.24e-06	5.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.24e-06	5.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.23e-06	5.94e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.21e-06	5.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.2e-06	5.92e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—type 2 diabetes mellitus	6.2e-06	5.91e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.19e-06	5.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.17e-06	5.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.15e-06	5.86e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.12e-06	5.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.11e-06	5.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.11e-06	5.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.1e-06	5.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.08e-06	5.79e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.07e-06	5.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	6.05e-06	5.77e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	5.93e-06	5.66e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	5.93e-06	5.66e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.92e-06	5.65e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.9e-06	5.62e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	5.89e-06	5.62e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.87e-06	5.59e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.86e-06	5.58e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.85e-06	5.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.8e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.8e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.8e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—INS—type 2 diabetes mellitus	5.78e-06	5.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.77e-06	5.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.77e-06	5.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.75e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.74e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.73e-06	5.47e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	5.72e-06	5.46e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.66e-06	5.4e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.65e-06	5.39e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.65e-06	5.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.65e-06	5.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.63e-06	5.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.63e-06	5.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.56e-06	5.31e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.56e-06	5.3e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.56e-06	5.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.54e-06	5.28e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.54e-06	5.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.53e-06	5.28e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.47e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	5.47e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.43e-06	5.18e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	5.43e-06	5.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	5.32e-06	5.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	5.31e-06	5.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.31e-06	5.06e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	5.3e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	5.21e-06	4.97e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	5.07e-06	4.83e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.07e-06	4.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.06e-06	4.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.05e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.04e-06	4.81e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.02e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	5.01e-06	4.78e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.96e-06	4.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.94e-06	4.71e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.94e-06	4.71e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.89e-06	4.66e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.84e-06	4.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	4.81e-06	4.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.8e-06	4.58e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.79e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.79e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.77e-06	4.55e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.77e-06	4.55e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.74e-06	4.52e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.73e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.71e-06	4.49e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.7e-06	4.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.67e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.66e-06	4.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.65e-06	4.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.65e-06	4.43e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	4.64e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.63e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.57e-06	4.36e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.54e-06	4.33e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.49e-06	4.28e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.45e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.44e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.42e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.41e-06	4.2e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—type 2 diabetes mellitus	4.4e-06	4.2e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.4e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.39e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.36e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.31e-06	4.11e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.27e-06	4.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-06	4.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	4.22e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.22e-06	4.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.22e-06	4.02e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	4.18e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.15e-06	3.96e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.15e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.09e-06	3.91e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.09e-06	3.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.08e-06	3.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.08e-06	3.89e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.07e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.06e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.06e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.99e-06	3.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.97e-06	3.78e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-06	3.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.88e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.86e-06	3.68e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.74e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.73e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.7e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.7e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.67e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.67e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.66e-06	3.49e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.66e-06	3.49e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.62e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.61e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.59e-06	3.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.58e-06	3.41e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.56e-06	3.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.48e-06	3.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.38e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.35e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.28e-06	3.13e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	3.04e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.17e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.14e-06	3e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.13e-06	2.98e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.12e-06	2.98e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.12e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.04e-06	2.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.97e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.94e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.94e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.88e-06	2.75e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.87e-06	2.73e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	2.82e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.79e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.76e-06	2.63e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	2.61e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	2.61e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.74e-06	2.61e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.73e-06	2.61e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	2.73e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.67e-06	2.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.6e-06	2.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.54e-06	2.43e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	2.52e-06	2.4e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.45e-06	2.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.4e-06	2.29e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	2.33e-06	2.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.1e-06	2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.94e-06	1.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.84e-06	1.76e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.7e-06	1.62e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	1.2e-05	CbGpPWpGaD
